Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis
NCT00297011Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2004
- Primary completion
- Mar 2007
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in herpes labialis comparing Valacyclovir + Temovate Gel with Placebo (2 arms). Primary endpoint: Maximum size of the primary lesion complex. Started Sep 2004; status: completed.
02
Drugs
valaciclovirclobetasol
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00297011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297011.